| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 526,300 | 439,600 | 542,100 | 275,100 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
| 542,100 | 275,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 372,300 | 314,900 | 434,900 | 308,700 | | Non Recurring |
-
|
-
|
-
| (432,200) | | Others | 155,400 | 182,200 | 65,700 | 223,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (36,700) | (74,300) | 41,500 | 175,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (28,400) | (57,500) | 41,500 | 175,600 | | Interest Expense | 8,300 | 8,300 | 8,500 | 10,000 | | Income Before Tax | (36,700) | (65,800) | 33,000 | 165,600 | | Income Tax Expense | (11,400) | 19,100 | 106,000 | (7,700) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,300) | (84,900) | (73,000) | 173,300 | | | Non-recurring Events | | Discontinued Operations | (1,300) | (26,300) | (1,800) | (551,600) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,600) | (111,200) | (74,800) | (378,300) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,600) | ($111,200) | ($74,800) | ($378,300) |
|
0.05% Nasdaq 
Income Statement
